Lv2
190 积分 2025-01-09 加入
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis
4天前
已关闭
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis
4天前
已关闭
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis
4天前
已关闭
Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
24天前
已完结
A Role for CTLA‐4‐Mediated Inhibitory Signals in Peripheral T Cell Tolerance?
1个月前
已完结
Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays
3个月前
已完结
High serum immunoglobulin D levels in systemic lupus erythematosus: more to be found?
3个月前
已完结
SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
4个月前
已完结
Statistical Methods of Screening Cut Point Determination in Immunogenicity Studies
4个月前
已完结
A Data Driven Strategy for Implementation of Singlicate Analysis in Ligand Binding Assays Used for the Determination of Anti-drug Antibodies to a Multidomain Biotherapeutic
5个月前
已完结
皖公网安备34019202002308
